PHARMACY

Upsher-Smith celebrates its centennial
As it marks a century in business, Upsher-Smith said its plans include diversifying and expanding its portfolio.
CVS Health’s Aetna inks 4-year agreement with Vitality Re X
As part of its long-term capital management strategy, Aetna has entered into a four-year reinsurance agreement with Vitality Re X.

Genentech appoints new CEO

Genentech has named Alexander Hardy its CEO effective March 1, succeeding Bill Anderson.
NACDS weighs in on DIR fee reform in comments to CMS

NACDS is making the case that DIR fee reform is necessary in its comments to the Centers for Medicare and Medicaid Services, which recently issued a proposed rule focused on reducing patient out-of-pocket costs.
BD unveils second-gen Nano pen needle

BD's second-generation BD Nano pen needle is designed to help people better manage their diabetes, the company said.
Dr. Reddy’s launches generic Diprivan

Dr. Reddy's is offering generic Diprivan (propofol) injectable emulsion, which had a market value of roughly $310 million for the year ended November 2018, according to IQVIA data.
Amerigen gets FDA nod for generic Adderall XR

Amerigen’s generic of Shire’s extended-release ADHD drug will be available in 5-, 10-, 15-, 20-, 25- and 30-mg dosage strengths.
Survey: Patients concerned about taking medication properly

Patients who lack confidence in taking medications properly blame it on a lack of time with physicians, according to a new survey from e-prescribing and medication management solutions company DrFirst.
CVS Health's Accordant gets NCQA case management accreditation

Accordant, a CVS Health company, has received its second three-year accreditation for case management from NCQA, demonstrating compliance with the organization's case management program standards.
Easing open enrollment uncertainty for patients

AmerisourceBergen’s Kelly Gasper discusses how pharmacists can play an integral role in helping patients navigate open enrollment and the potential changes it brings.